reports
Mithra enters into exclusive negotiations with Gedeon Richter and secu...
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of , Mithra has selected the offer submitted by Gedeon Richter, which relates to Estetra SRL, Neuralis SA and specific assets held by Mithra R&D SA related to the E4 platform, as a basis for further negotiations and decided to grant exclusivity to Gedeon Richter for the purpose of such negotiation...
Euronext upgraded to ‘BBB+, Positive Outlook‘ by S&P
Euronext upgraded to ‘BBB+, Positive Outlook‘ by S&P Contacts Media Contact Investor Relations Amsterdam Brussels 27 Dublin 13 Lisbon 4 Milan 12 Oslo Paris 45 Euronext upgraded to ‘BBB+, Positive Outlook‘ by S&P Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 30 April 2024 – Euronext, the leading pan-European market infrastructure, today welcomes the decision of S&P to upgrade Euronext from ‘BBB+, Stable Outlook’ to ‘BBB+, Positive Outlook’. S&P decision reflects the approaching completion of the integration of the Borsa Italia...
Mithra updates on offers received in the context of its monetization p...
Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023 Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure full repayment of all creditors of Mithra, and, therefore, the offers do not allow to create value for Mithra’s shareholders at the present time.Mithra has requested the suspension of trading of its shares on Euronext Brussels pending continuing negotiations with offering parties.Mithra postpones...
Mithra secures court protection measures to advance monetization proce...
Mithra secures court protection measures to advance monetization process Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing Organization.Approval of Judicial Reorganization Proceedings for Novalon SA, facilitating an amicable agreement with some creditors and restructuring the debt of Mithra's complex therapeutics business.Mithra Advances Monetization Process with Court Protection Measures, marking significant milestones in the company's commitment to maximizing ...
- Jacob Mekhael
- Thibault Leneeuw
- Thomas Vranken
Euronext announces volumes for March 2024
Euronext announces volumes for March 2024 Contacts Media Contact Investor Relations Amsterdam Brussels 17 Dublin 13 Lisbon 97 Milan 56 Oslo Paris 45 Euronext announces volumes for March 2024 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 8 April 2024 – Euronext, the leading pan-European market infrastructure, today announced trading volumes for March 2024. Monthly and historical volume tables are available at this address: CONTACTS MEDIA – Europe A...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Sharad Kumar S.P
- Thomas Couvreur
- Thomas Vranken
- Wim Lewi
Euronext to acquire Global Rate Set Systems to strengthen its index fr...
Euronext to acquire Global Rate Set Systems to strengthen its index franchise Contacts Media Contact Investor Relations Amsterdam Brussels 17 Dublin 13 Lisbon 4 Milan 12 Oslo Paris 45 Euronext to acquire Global Rate Set Systems to strengthen its index franchise Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 29 March 2024 – Euronext, the leading pan-European market infrastructure, today announces that it has entered into an agreement to acquire 75% of the share capital of Global Rate Set Systems (GRSS), a leading provider of ser...
Euronext publishes its 2023 Universal Registration Document
Euronext publishes its 2023 Universal Registration Document Contacts MediaContact Investor RelationsAmsterdam Brussels 17Dublin 13Lisbon 4 Milan 12Oslo Paris 45 Euronext publishes its 2023 Universal Registration Document Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 28 March 2024 – Euronext, the leading pan-European market infrastructure, today announces that it has filed its 2023 Universal Registration Document, prepared in ESEF format (European Single Electronic Format), including the 2023 Annual Financial Statements and Directors’ Report to the Stichting Autoriteit...
Convening of the Annual General Meeting of Euronext N.V.
Convening of the Annual General Meeting of Euronext N.V. Contacts MediaContact Investor RelationsAmsterdam Brussels 17Dublin 13Lisbon 4 Milan 12Oslo Paris 45 Convening of the Annual General Meeting of Euronext N.V. Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 28 March 2024 – Euronext today announced that the Annual General Meeting (“AGM”) will take place on Wednesday 15 May 2024 at 10.30 CEST at Beursplein 5, 1012 JW Amsterdam, The Netherlands. The agenda for the meeting is as follows: Opening Presentation of the Chief Executive Officer (discussion item)Annual rep...
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Sharad Kumar S.P
- Thibault Leneeuw
- Thomas Vranken
- Wim Hoste
- Wim Lewi
Euronext announces volumes for February 2024
Euronext announces volumes for February 2024 Contacts MediaContact Investor RelationsAmsterdam Brussels 17Dublin 13Lisbon 97 Milan 56Oslo Paris 45 Euronext announces volumes for February 2024 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 8 March 2024 – Euronext, the leading pan-European market infrastructure, today announced trading volumes for February 2024. Monthly and historical volume tables are available at this address: CONTACTS MEDIA – EuropeAurélie Cohen 45 Andrea Monzani 13 AmsterdamMarianne Aalders 3BrusselsMarianne Aalders DublinAndrea Monzani 13dub...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Thomas Vranken
Mithra FY23: better than expected operations, but cash and liabilities...
Mithra's FY23 results reveal € 40m revenues and € -48m REBITDA somewhat higher than our expectations, although a € 74m impairment on the CMO and Zoreline tanks the net loss to € 173.5m. While the monetisation process for (parts of) the business is ongoing, we estimate that little value could be left for shareholders. We therefore adopt a Sell rating (previously Reduce) and decrease our TP from € 1.0 to € 0.1.
- Guy Sips
- Jacob Mekhael
- Thibault Leneeuw
- Thomas Vranken
- Thomas Vranken
Euronext N.V.: 1 director
A director at Euronext N.V. sold 3,470 shares at 83.777EUR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Hilde Van Boxstael
- Kristof Samoy
- Michiel Declercq
- Thomas Couvreur
- Thomas Vranken
- Wim Lewi
- Thomas Vranken
Mithra FIRST LOOK: Mayne Pharma's 1H24 results
Mithra's commercial partner in the US, Mayne Pharma, reported its 1H24 results for the period Jul-Dec '23. Nextstellis sales were up 94% vs. 2H23, and reached USD 13.8m, driven by a 33% increase in cycles and an improved net selling price. Although the revenue trend turns positive, it will likely not move the needle for Mithra in a major way in the context of its current cash runway. We expect to see more detail in next week's FY23 update.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.